Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.25 USD | +1.87% | -3.65% | 0.00% |
Apr. 22 | Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target | MT |
Apr. 22 | Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 205M |
---|---|---|---|---|---|
Net income 2024 * | -68M | Net income 2025 * | -94M | EV / Sales 2024 * | - |
Net cash position 2024 * | 30.75M | Net cash position 2025 * | 36.28M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.74
x | P/E ratio 2025 * |
-2.47
x | Employees | 72 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.54% |
1 day | +1.87% | ||
1 week | -3.65% | ||
Current month | +1.43% | ||
1 month | -1.07% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 9.19 | +1.21% | 38,533 |
24-06-03 | 9.08 | -0.44% | 39,182 |
24-05-31 | 9.12 | +6.67% | 33,912 |
24-05-30 | 8.55 | -1.95% | 41,075 |
24-05-29 | 8.72 | -9.17% | 58,323 |
Delayed Quote Nasdaq, June 04, 2024 at 03:58 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 205M | |
+16.73% | 123B | |
+13.04% | 107B | |
-5.80% | 24.01B | |
+1.69% | 22.59B | |
-10.09% | 18.16B | |
-40.52% | 16.84B | |
-14.00% | 16.23B | |
+1.18% | 13.43B | |
+24.18% | 11.32B |
- Stock Market
- Equities
- BOLD Stock